Search Results - "Ning, Changwen"
-
1
Folate transporter dynamics and therapy with classic and tumor-targeted antifolates
Published in Scientific reports (18-03-2021)“…There are three major folate uptake systems in human tissues and tumors, including the reduced folate carrier (RFC), folate receptors (FRs) and proton-coupled…”
Get full text
Journal Article -
2
Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19
Published in Scientific reports (06-11-2023)“…Immune inhibitory receptors (IRs) play a critical role in the regulation of immune responses to various respiratory viral infections. However, in coronavirus…”
Get full text
Journal Article -
3
Natural plant flavonoid apigenin directly disrupts Hsp90/Cdc37 complex and inhibits pancreatic cancer cell growth and migration
Published in Journal of functional foods (01-10-2015)“…•Apigenin can be digested, released and absorbed into blood circulation to accumulate.•Apigenin directly inhibited Hsp90/Cdc37 interaction with structural…”
Get full text
Journal Article -
4
Abstract 4791: Impact of folate transport redundancies on the therapy with tumor-targeted and untargeted antifolates
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Folates participate in one-carbon (C1) transfer reactions in normal and cancer cells. Antifolate therapeutics disrupt cytosolic C1 metabolism, and…”
Get full text
Journal Article -
5
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2- d ]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Published in Molecular pharmacology (01-01-2020)“…Folate-dependent one-carbon (C1) metabolism is compartmentalized in the mitochondria and cytosol and is a source of critical metabolites for proliferating…”
Get full text
Journal Article -
6
Novel Pyrrolo[3,2- d ]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy
Published in Molecular cancer therapeutics (01-10-2019)“…Folate-dependent one-carbon (C1) metabolism is compartmentalized into the mitochondria and cytosol and supports cell growth through nucleotide and amino acid…”
Get full text
Journal Article -
7
-
8
Abstract 4794: Targeting mitochondrial and cytosolic one carbon metabolism of pancreatic adenocarcinoma via the proton-coupled folate transporter with novel 5-substituted pyrrolo[3,2- d ]pyrimidine analogs
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Pancreatic cancer (PaC) represents the 4th leading cause of cancer-related deaths in the US with a mortality rate of 99%. The 5-year overall survival…”
Get full text
Journal Article -
9
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
Published in Oncotarget (04-07-2017)“…Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease in urgent need of newer therapeutic modalities. Majority of patients with PDAC have mutations in…”
Get full text
Journal Article -
10
Abstract 2992: Cellular pharmacodynamics of mitochondrial one-carbon metabolism-targeting 5-substituted pyrrolo[3,2- d ]pyrimidine antifolates
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Folate-dependent one-carbon metabolism (1CM) is compartmentalized in the mitochondria and cytosol and generates a number of metabolites critical to…”
Get full text
Journal Article -
11
Novel Pyrrolo3,2-dpyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy
Published in Molecular cancer therapeutics (01-10-2019)“…Folate-dependent one-carbon (C1) metabolism is compartmentalized into the mitochondria and cytosol and supports cell growth through nucleotide and amino acid…”
Get full text
Journal Article